Angiotensin-converting enzyme insertion/deletion polymorphism in hypertrophic cardiomyopathy: An Egyptian case control study

Hypertrophic Cardiomyopathy (HCM) is a disease characterized by genetic and phenotypic heterogeneity. Renin–angiotensin–aldosteron be system (RAAS) is a potential disease modifier. The aim of the present case control study is evaluation of the controversial role of ACE I/D polymorphism in HCM among...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Egyptian heart journal Jg. 66; H. 1; S. 1 - 2
Hauptverfasser: Kassem, Heba Sh, Algendy, Sherif A., Azer, Remon S., Moharem, Sarah, Ayad, Maha S., Magdy, Gehan, Elguindy, Ahmed, Yacoub, Magdi H.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Elsevier B.V 01.03.2014
SpringerOpen
Schlagworte:
ISSN:1110-2608, 2090-911X
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Hypertrophic Cardiomyopathy (HCM) is a disease characterized by genetic and phenotypic heterogeneity. Renin–angiotensin–aldosteron be system (RAAS) is a potential disease modifier. The aim of the present case control study is evaluation of the controversial role of ACE I/D polymorphism in HCM among Egyptians. The study comprised 211 unrelated HCM patients (138 sporadic, 73 familial) and 203 age and sex matched ECG screened healthy volunteers. ACE I/D polymorphism was determined using previously described PCR and gel electrophoresis based method. Distribution of ACE genotype among the Egyptian controls was in Hardy-Weinberg equilibrium (P=0.778) but not in HCM patients (P=0.0010). The ACE DD genotype was significantly higher among HCM patients (P=0.049), particularly in sporadic HCM group compared with familial cases (P=0.0001). In addition, the distribution of D allele was significantly higher in HCM patients carrying sarcomeric mutations in TNNT2 and MYH7, (P=0.0476). There was no observed significant effect of the ACE genotypes on the phenotypic expression of the disease. The finding of higher frequency of DD genotype among HCM patients compared to healthy volunteers, particularly so, in sporadic cases suggests that HCM expression is possibly influenced by a genetically predisposed milieu partially determined by the ACE I/D variants. Despite the lack of significant correlation between I/D variants and clinicopathologic characteristics of the HCM patients, however, the higher prevalence of D allele among TNNT2 and MYH7 mutation carriers may contribute to the variable disease outcome among sarcomeric gene positive cases, such a correlation can only be proven through long term follow up studies.
AbstractList Hypertrophic Cardiomyopathy (HCM) is a disease characterized by genetic and phenotypic heterogeneity. Renin–angiotensin–aldosteron be system (RAAS) is a potential disease modifier. The aim of the present case control study is evaluation of the controversial role of ACE I/D polymorphism in HCM among Egyptians. The study comprised 211 unrelated HCM patients (138 sporadic, 73 familial) and 203 age and sex matched ECG screened healthy volunteers. ACE I/D polymorphism was determined using previously described PCR and gel electrophoresis based method. Distribution of ACE genotype among the Egyptian controls was in Hardy-Weinberg equilibrium (P=0.778) but not in HCM patients (P=0.0010). The ACE DD genotype was significantly higher among HCM patients (P=0.049), particularly in sporadic HCM group compared with familial cases (P=0.0001). In addition, the distribution of D allele was significantly higher in HCM patients carrying sarcomeric mutations in TNNT2 and MYH7, (P=0.0476). There was no observed significant effect of the ACE genotypes on the phenotypic expression of the disease. The finding of higher frequency of DD genotype among HCM patients compared to healthy volunteers, particularly so, in sporadic cases suggests that HCM expression is possibly influenced by a genetically predisposed milieu partially determined by the ACE I/D variants. Despite the lack of significant correlation between I/D variants and clinicopathologic characteristics of the HCM patients, however, the higher prevalence of D allele among TNNT2 and MYH7 mutation carriers may contribute to the variable disease outcome among sarcomeric gene positive cases, such a correlation can only be proven through long term follow up studies.
Hypertrophic Cardiomyopathy (HCM) is a disease characterized by genetic and phenotypic heterogeneity. Renin–angiotensin–aldosteron be system (RAAS) is a potential disease modifier. The aim of the present case control study is evaluation of the controversial role of ACE I/D polymorphism in HCM among Egyptians. Subjects and methods: The study comprised 211 unrelated HCM patients (138 sporadic, 73 familial) and 203 age and sex matched ECG screened healthy volunteers. ACE I/D polymorphism was determined using previously described PCR and gel electrophoresis based method. Results: Distribution of ACE genotype among the Egyptian controls was in Hardy-Weinberg equilibrium (P = 0.778) but not in HCM patients (P = 0.0010). The ACE DD genotype was significantly higher among HCM patients (P = 0.049), particularly in sporadic HCM group compared with familial cases (P = 0.0001). In addition, the distribution of D allele was significantly higher in HCM patients carrying sarcomeric mutations in TNNT2 and MYH7, (P = 0.0476). There was no observed significant effect of the ACE genotypes on the phenotypic expression of the disease. Conclusion: The finding of higher frequency of DD genotype among HCM patients compared to healthy volunteers, particularly so, in sporadic cases suggests that HCM expression is possibly influenced by a genetically predisposed milieu partially determined by the ACE I/D variants. Despite the lack of significant correlation between I/D variants and clinicopathologic characteristics of the HCM patients, however, the higher prevalence of D allele among TNNT2 and MYH7 mutation carriers may contribute to the variable disease outcome among sarcomeric gene positive cases, such a correlation can only be proven through long term follow up studies.
Author Moharem, Sarah
Algendy, Sherif A.
Elguindy, Ahmed
Ayad, Maha S.
Yacoub, Magdi H.
Kassem, Heba Sh
Magdy, Gehan
Azer, Remon S.
Author_xml – sequence: 1
  givenname: Heba Sh
  surname: Kassem
  fullname: Kassem, Heba Sh
  organization: BA HCM National Program Bibliotheca Alexandrina and Magdi Yacoub Heart Foundation, Aswan Heart Center, Egypt
– sequence: 2
  givenname: Sherif A.
  surname: Algendy
  fullname: Algendy, Sherif A.
  organization: BA HCM National Program Bibliotheca Alexandrina and Magdi Yacoub Heart Foundation, Aswan Heart Center, Egypt
– sequence: 3
  givenname: Remon S.
  surname: Azer
  fullname: Azer, Remon S.
  organization: BA HCM National Program Bibliotheca Alexandrina and Magdi Yacoub Heart Foundation, Aswan Heart Center, Egypt
– sequence: 4
  givenname: Sarah
  surname: Moharem
  fullname: Moharem, Sarah
  organization: BA HCM National Program Bibliotheca Alexandrina and Magdi Yacoub Heart Foundation, Aswan Heart Center, Egypt
– sequence: 5
  givenname: Maha S.
  surname: Ayad
  fullname: Ayad, Maha S.
  organization: BA HCM National Program Bibliotheca Alexandrina and Magdi Yacoub Heart Foundation, Aswan Heart Center, Egypt
– sequence: 6
  givenname: Gehan
  surname: Magdy
  fullname: Magdy, Gehan
  organization: BA HCM National Program Bibliotheca Alexandrina and Magdi Yacoub Heart Foundation, Aswan Heart Center, Egypt
– sequence: 7
  givenname: Ahmed
  surname: Elguindy
  fullname: Elguindy, Ahmed
  organization: BA HCM National Program Bibliotheca Alexandrina and Magdi Yacoub Heart Foundation, Aswan Heart Center, Egypt
– sequence: 8
  givenname: Magdi H.
  surname: Yacoub
  fullname: Yacoub, Magdi H.
  organization: BA HCM National Program Bibliotheca Alexandrina and Magdi Yacoub Heart Foundation, Aswan Heart Center, Egypt
BookMark eNp9UU1r3DAQFSWFbtP8gN70B-xoJPlD7WkJaRoI5NJCb0IrjXdlbMlIbsClP77abukxOkjDm3lv9HjvyVWIAQn5CKwGBu3tWONprDkDUQOvGZNvyI4zxSoF8OOK7ACAVbxl_Ttyk_PIyml5J5jckd_7cPRxxZB9qGwML5hWH44Uw69tRupDPgMx3Dqc8FzQJU7bHNNy8nkufXraljKSYgEstSY5H-ctLmY9bZ_oPtD747as3oTSy0jLijI70bz-dNsH8nYwU8abf-81-f7l_tvd1-rp-eHxbv9UWc6ErAbTgWocHpx0rlflbodWuEYNB2DcAZjGcMFE2zgrDT80HPoWu14cGtUDc-KaPF50XTSjXpKfTdp0NF7_BWI6alNc2gk16xBASgGDlLJT1ijnTIPWiK5XqmuKFly0bIo5Jxz-6wHT5zT0qEsa-pyGBq5LGoXz-cLBYvLFY9LZegwWnU9o1_IL_wr7DzGxlxA
ContentType Journal Article
Copyright 2013
Copyright_xml – notice: 2013
DBID 6I.
AAFTH
AAYXX
CITATION
DOA
DOI 10.1016/j.ehj.2013.12.004
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2090-911X
EndPage 2
ExternalDocumentID oai_doaj_org_article_07e114431f44479ca9dda5eca3789975
10_1016_j_ehj_2013_12_004
S1110260813001233
GroupedDBID ---
--K
0R~
0SF
4.4
457
5VS
6I.
7X7
8FI
8FJ
AACTN
AAEDT
AAEDW
AAFTH
AAFWJ
AAIKJ
AAKKN
AALRI
AAXUO
AAYZJ
ABMAC
ABUWG
ACACY
ACGFS
ADBBV
ADEZE
AEXQZ
AFGXO
AFKRA
AFNRJ
AFPKN
AFWDF
AGHFR
AHBXF
AITUG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
C24
C6C
CCPQU
EBS
EJD
FDB
FYUFA
GROUPED_DOAJ
HMCUK
HYE
HZ~
IAO
IHR
INH
IPNFZ
IXB
KQ8
M41
NCXOZ
O-L
O9-
OK1
PIMPY
RIG
ROL
RPM
RSV
SEL
SOJ
SSZ
UKHRP
XH2
AAYWO
AAYXX
ABEEZ
ACULB
ACVFH
ADCNI
ADVLN
AEUPX
AFFHD
AFPUW
AIGII
AKBMS
AKRWK
AKYEP
CITATION
H13
ITC
PGMZT
PHGZM
PHGZT
ID FETCH-LOGICAL-c2034-fa7195debd4dd89d4d6f63d59fb102d11a5a230365dc4a2b52186e783b59810d3
IEDL.DBID DOA
ISSN 1110-2608
IngestDate Fri Oct 03 12:39:07 EDT 2025
Sat Nov 29 06:41:44 EST 2025
Fri Feb 23 02:30:08 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Angiotensin-converting enzyme Insertion/Deletion polymorphism
Hypertrophic cardiomyopathy
Egypt
Language English
License http://creativecommons.org/licenses/by-nc-nd/3.0
https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2034-fa7195debd4dd89d4d6f63d59fb102d11a5a230365dc4a2b52186e783b59810d3
OpenAccessLink https://doaj.org/article/07e114431f44479ca9dda5eca3789975
PageCount 2
ParticipantIDs doaj_primary_oai_doaj_org_article_07e114431f44479ca9dda5eca3789975
crossref_primary_10_1016_j_ehj_2013_12_004
elsevier_sciencedirect_doi_10_1016_j_ehj_2013_12_004
PublicationCentury 2000
PublicationDate March 2014
2014-03-00
2014-03-01
PublicationDateYYYYMMDD 2014-03-01
PublicationDate_xml – month: 03
  year: 2014
  text: March 2014
PublicationDecade 2010
PublicationTitle The Egyptian heart journal
PublicationYear 2014
Publisher Elsevier B.V
SpringerOpen
Publisher_xml – name: Elsevier B.V
– name: SpringerOpen
SSID ssj0000627304
Score 1.8738413
Snippet Hypertrophic Cardiomyopathy (HCM) is a disease characterized by genetic and phenotypic heterogeneity. Renin–angiotensin–aldosteron be system (RAAS) is a...
SourceID doaj
crossref
elsevier
SourceType Open Website
Index Database
Publisher
StartPage 1
SubjectTerms Angiotensin-converting enzyme Insertion/Deletion polymorphism
Egypt
Hypertrophic cardiomyopathy
Title Angiotensin-converting enzyme insertion/deletion polymorphism in hypertrophic cardiomyopathy: An Egyptian case control study
URI https://dx.doi.org/10.1016/j.ehj.2013.12.004
https://doaj.org/article/07e114431f44479ca9dda5eca3789975
Volume 66
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: Directory of Open Access Journals
  customDbUrl:
  eissn: 2090-911X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000627304
  issn: 1110-2608
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlhNJLSJqWbj6KDj0FRGxrZNm5bUJCLw09JJCbkDVy4tC1l91tYUN-fEayHfZScsnFGMlI5nmsmZEe8xj7kVQSUSOKOvMoAFwubA5KZJSKKVdhkVUuik3o6-vi7q78vSH1FThhfXngHrjTRHsK2cnN1QCgS2dLRKu8s1JTqqBj9dJElxvJVL8Gk1uO2oH0LyeCgvZiPNKM5C7_8BhoXTJuBQ4ibaNTirX7N3zThr-52mU7Q6DIp_0L7rEPvv3MPv4ajsL32fO0vW-6yD9vReSOh3oA99y3T-uZ500bjtkJ9NOgdBNu-Lz7Q4k-4dosZ9TPHygFXawWHTU47iIvdbbugkTx-oxPW34ZFMrIeqhv6fnAaeexHu0Xdnt1eXPxUwxSCsJliQRRW52WCn2FgFiUdM3rXKIq64oiDExTq2wWvJlCBzarVJCq8rqQlSqLNEH5lW21Xeu_MQ45eA0oFa0FUJN7c5lzBTqpbAGphwk7GbE0875ihhmpZI-GgDcBeJNmhoCfsPOA9uuDodh1bCATMIMJmLdMYMJg_FZmiBv6eICGav4_98F7zH3IPtGQ0LPSjtjWavHXH7Nt92_VLBffo1G-AL695qk
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Angiotensin-converting+enzyme+insertion%2Fdeletion+polymorphism+in+hypertrophic+cardiomyopathy%3A+An+Egyptian+case+control+study&rft.jtitle=The+Egyptian+heart+journal&rft.au=Heba+Sh.+Kassem&rft.au=Sherif+A.+Algendy&rft.au=Remon+S.+Azer&rft.au=Sarah+Moharem&rft.date=2014-03-01&rft.pub=SpringerOpen&rft.issn=1110-2608&rft.volume=66&rft.issue=1&rft.spage=1&rft.epage=2&rft_id=info:doi/10.1016%2Fj.ehj.2013.12.004&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_07e114431f44479ca9dda5eca3789975
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1110-2608&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1110-2608&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1110-2608&client=summon